New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Innate Pharma S.A.
IPHA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

169M

Biotechnology

Next Earning date - 27 Mar 2025

169M

Biotechnology

Next Earning date - 27 Mar 2025

2.09USD

Shape0.01 ( 0.48%)
Market Closed (as of Mar 06, 21:00 EDT)
favorite-chart

Relative Strenght

87
favorite-chart

Volume Buzz

-99%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

40%

Quote Panel

Shape
Updated March 20, 2025
1W 1.00 % 1M -9.82 % 3M -3.81 % 1Y -16.18 %

Key Metrics

Shape
  • Market Cap

    169.25M


  • Shares Outstanding

    83.81M


  • Share in Float

    31.56M


  • Dividende

    0


  • Earning Date

    27 Mar 2025


  • Price Target

    2.0194


  • Average Volume

    253596


  • Beta

    0.859


  • Range

    1.29-3.511


  • Industry

    Biotechnology


  • Website

    https://www.innate-pharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

IPHA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$80M

Shape548%

2025-Revenue

$0.01

Shape103%

2025-EPS

$34M

Shape-34%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.19

arrow
arrow

N/A

-0.52
vs 0.3

Q2.20

arrow
arrow

N/A

-0.13
vs 0.2

Q4.20

arrow
arrow

N/A

-0.83
vs -0.52

Q2.21

arrow
arrow

N/A

-0.36
vs -0.13

Q4.21

arrow
arrow

N/A

-0.41
vs -0.83

Q2.22

arrow
arrow

+123%

0.08
vs -0.36

Q4.22

arrow
arrow

N/A

-0.87
vs -0.41

Q2.23

arrow
arrow

-72%

0.02
vs 0.08

Q4.23

arrow
arrow

N/A

-0.06
vs -0.87

Q2.24

arrow
arrow

N/A

-0.16
vs 0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.19

arrow
arrow

-75%

17.4M  vs 71M

Q2.20

arrow
arrow

-29%

36.7M  vs 51.6M

Q4.20

arrow
arrow

+55%

27M  vs 17.4M

Q2.21

arrow
arrow

-75%

9.3M  vs 36.7M

Q4.21

arrow
arrow

-90%

2.8M  vs 27M

Q2.22

arrow
arrow

+343%

41.3M  vs 9.3M

Q4.22

arrow
arrow

+197%

8.3M  vs 2.8M

Q2.23

arrow
arrow

-14%

35.3M  vs 41.3M

Q4.23

arrow
arrow

+158%

21.4M  vs 8.3M

Q2.24

arrow
arrow

-65%

12.3M  vs 35.3M

Return on EquityShape

status-upQoQ

Q4.20

arrow
arrow

-34%

-0.34
vs -0.05

Q2.21

arrow
arrow

-18%

-0.18
vs -0.34

Q4.21

arrow
arrow

-27%

-0.27
vs -0.18

Q2.22

arrow
arrow

+5%

0.05
vs -0.27

Q4.22

arrow
arrow

-119%

-1.19
vs 0.05

Q2.23

arrow
arrow

+3%

0.03
vs -1.19

Q4.23

arrow
arrow

-18%

-0.18
vs 0.03

Q2.24

arrow
arrow

-86%

-0.86
vs -0.18

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

8

8
vs 10

-20%

Q2.23

arrow
arrow

9

9
vs 8

13%

Q3.23

arrow
arrow

8

8
vs 9

-11%

Q4.23

arrow
arrow

8

8
vs 8

NA

Q1.24

arrow
arrow

9

9
vs 8

13%

Q2.24

arrow
arrow

8

8
vs 9

-11%

Q3.24

arrow
arrow

8

8
vs 8

NA

Q4.24

arrow
arrow

9

9
vs 8

13%

Earnings Growth

Latest News